- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02582879
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia (informCLL)
July 19, 2022 updated by: Pharmacyclics LLC.
The study is designed as a multicenter, prospective, observational registry of CLL/SLL patients who are initiating approved oral kinase inhibitors, BCL-2 inhibitors or other approved anti-CLL therapies/regimens.
The study will characterize treatment patterns and their association with patient characteristics, healthcare resource utilization, and clinical outcomes, as well as patient-reported outcome (PRO) measures.
Study Overview
Status
Completed
Conditions
Detailed Description
This multicenter, prospective, observational registry of CLL patients is designed to characterize and describe treatment patterns for those initiating treatment with approved oral kinase inhibitors and other approved anti-CLL therapies/ regimens.
The registry will provide information on regimens used to treat first-line and later lines of CLL as well as the sequencing of treatment regimens.
The registry will also evaluate the association of these treatment patterns with patient characteristics, healthcare resource utilization, and functional outcomes including patient-reported HRQoL.
These data will provide information to physicians that may help guide clinical practice and appropriate use of therapies, and will also provide information on HRQoL and healthcare resource utilization that will be of interest to healthcare decision makers.
Study Type
Observational
Enrollment (Actual)
1504
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alabama
-
Huntsville, Alabama, United States, 35805
- Clearview Cancer Institute
-
Muscle Shoals, Alabama, United States, 35661
- Northwest Alabama Cancer Center, Pc
-
-
Arizona
-
Glendale, Arizona, United States, 85308
- Arizona Oncology Associates, PC - HAL
-
Phoenix, Arizona, United States, 85016
- Arizona Oncology Associates, PC - HAL
-
Phoenix, Arizona, United States, 85027
- Arizona Oncology Associates, PC - HAL
-
Tempe, Arizona, United States, 85284
- Arizona Oncology Associates, PC - HAL-Scottsdale
-
-
Arkansas
-
Fort Smith, Arkansas, United States, 72903
- Mercy Research
-
Hot Springs, Arkansas, United States, 71913
- Genesis Cancer Center
-
Jonesboro, Arkansas, United States, 72401
- Clopton Clinic of Jonesboro, Inc.
-
Little Rock, Arkansas, United States, 72205
- CARTI - Central Arkansas Radiation Therapy Institute
-
-
California
-
Concord, California, United States, 94520
- John Muir Health
-
Oceanside, California, United States, 92056
- North County Oncology Medical Clinic
-
Saint Helena, California, United States, 94574
- Gregory Smith, MD (Private Practice)
-
Santa Barbara, California, United States, 93105
- Sansum Clinic
-
Santa Rosa, California, United States, 95403
- St Joseph Heritage Healthcare
-
Solvang, California, United States, 93463
- Sansum Clinic
-
Vallejo, California, United States, 94589
- Solano Hematology Oncology
-
-
Colorado
-
Aurora, Colorado, United States, 80012
- Rocky Mountain Cancer Centers, LLP- Aurora
-
Boulder, Colorado, United States, 80303
- Rocky Mountain Cancer Centers, LLP- Boulder
-
Colorado Springs, Colorado, United States, 80907
- Rocky Mountain Cancer Centers
-
Denver, Colorado, United States, 80218
- Rocky Mountain Cancer Centers, LLP
-
Denver, Colorado, United States, 80220
- Rocky Mountain Cancer Centers, LLP
-
Lakewood, Colorado, United States, 80228
- Rocky Mountain Cancer Centers, LLP- Lakewood
-
Littleton, Colorado, United States, 80120-4413
- Rocky Mountain Cancer Centers, LLP- Littleton
-
Lone Tree, Colorado, United States, 80124
- Rocky Mountain Cancer Centers, LLP- Sky Ridge
-
Longmont, Colorado, United States, 80501
- Rocky Mountain Cancer Centers, LLP- Longmont
-
Parker, Colorado, United States, 80138
- Rocky Mountain Cancer Centers, LLP- Parker
-
Pueblo, Colorado, United States, 81008
- Rocky Mountain Cancer Centers, LLP- Pueblo
-
Thornton, Colorado, United States, 80260
- Rocky Mountain Cancer Centers, LLP- Thornton
-
-
Florida
-
Boynton Beach, Florida, United States, 33426
- University Cancer Institute, LLC
-
Fort Lauderdale, Florida, United States, 33308
- Broward Oncology Associates, PA
-
Jacksonville, Florida, United States, 32207
- Baptist MD Anderson Cancer Center
-
Jacksonville, Florida, United States, 32082
- Cancer Specialists, LLC
-
Lakeland, Florida, United States, 33805
- Lakeland Regional Health Systems Inc
-
Lakeland, Florida, United States, 33805
- Watson Clinic Cancer and Research Center
-
Pensacola, Florida, United States, 32504
- Sacred Heart Cancer Center
-
-
Georgia
-
Albany, Georgia, United States, 31701
- Phoebe Putney Memorial Hospital
-
Augusta, Georgia, United States, 30912
- Georgia Cancer Center at Augusta University
-
Brunswick, Georgia, United States, 31520
- Southeast Georgia Physician Associates Hematology & Oncology
-
-
Illinois
-
Chicago, Illinois, United States, 60637
- The University of Chicago
-
Harvey, Illinois, United States, 60426
- Ingalls Memorial Hospital
-
Normal, Illinois, United States, 61761
- Mid-Illinois Hematology & Oncology Associates,Ltd.
-
Peoria, Illinois, United States, 61615-7828
- Illinois Cancer Care, P.C.
-
Rockford, Illinois, United States, 61108
- OSF Saint Anthony Medical Center
-
Skokie, Illinois, United States, 60077
- Orchard Healthcare Research Inc.
-
Tinley Park, Illinois, United States, 60487
- Healthcare Research Network III, LLC
-
-
Indiana
-
Anderson, Indiana, United States, 46016
- St. Vincent Anderson Regional Hospital
-
Indianapolis, Indiana, United States, 46260
- Investigative Clinical Research of Indiana, LLC
-
Indianapolis, Indiana, United States, 46219
- Community Health Network
-
Lafayette, Indiana, United States, 47905
- Horizon Oncology Research, Inc
-
South Bend, Indiana, United States, 46601
- Memorial Medical Group Clinical Research Institute
-
Vincennes, Indiana, United States, 47591
- Good Samaritan Hospital
-
-
Iowa
-
Ames, Iowa, United States, 50010-3014
- McFarland Clinic, P.C.
-
Cedar Rapids, Iowa, United States, 52402
- Physicians Clinic of Iowa
-
Waterloo, Iowa, United States, 50702
- Covenant Clinic
-
-
Kansas
-
Topeka, Kansas, United States, 66606
- Cotton-O'Neil Clinical Research Center, Hematology and Oncology
-
-
Kentucky
-
Mount Sterling, Kentucky, United States, 40353
- Montgomery Cancer Center
-
Paducah, Kentucky, United States, 42003
- West Ky Hematology & Oncology Group, PSC
-
-
Louisiana
-
Covington, Louisiana, United States, 70433
- Pontchartrain Cancer Center
-
New Orleans, Louisiana, United States, 70112
- Tulane University
-
Shreveport, Louisiana, United States, 71103
- Willis-Knighton Cancer Center
-
Shreveport, Louisiana, United States, 71105
- Christus Cancer Treatment Center
-
-
Maine
-
Lewiston, Maine, United States, 04240
- Maine Research Associates
-
Rockport, Maine, United States, 04856
- Penobscot Bay Medical Center
-
Scarborough, Maine, United States, 04074
- Maine Center For Cancer Medicine
-
-
Maryland
-
Cumberland, Maryland, United States, 21502
- Western Maryland Health System
-
Hagerstown, Maryland, United States, 21740
- Antietam Oncology and Hematology Group PC
-
-
Massachusetts
-
Pittsfield, Massachusetts, United States, 01201
- Berkshire Hematology Oncology, PC
-
Plymouth, Massachusetts, United States, 02360
- Beth Israel Deaconess Hospital- Plymouth
-
-
Michigan
-
Kalamazoo, Michigan, United States, 49007
- West Michigan Cancer Center
-
Novi, Michigan, United States, 48374-1233
- St John Providence Hospital
-
-
Minnesota
-
Saint Cloud, Minnesota, United States, 56303
- Coborn Cancer Center
-
-
Mississippi
-
Jackson, Mississippi, United States, 39202
- Jackson Oncology Associates
-
-
Missouri
-
Bolivar, Missouri, United States, 65613
- Central Cancer Care Center
-
Jefferson City, Missouri, United States, 65109
- Jefferson City Medical Group
-
Saint Joseph, Missouri, United States, 64506
- Heartland Regional Medical Center d/b/a Cancer Care St. Joseph Mosaic Life Care
-
-
Montana
-
Billings, Montana, United States, 59102
- St. Vincent Frontier Cancer Center
-
-
Nebraska
-
Hastings, Nebraska, United States, 68901
- Mary Lanning Healthcare Morrison Cancer Center
-
Lincoln, Nebraska, United States, 68510
- Southeast Nebraska Cancer Center
-
Lincoln, Nebraska, United States, 68506
- Nebraska Hematology-Oncology, P.C
-
Omaha, Nebraska, United States, 68106
- Cancer Alliance of Nebraska
-
-
New Jersey
-
Elizabeth, New Jersey, United States, 07207
- Trinitas Hospital
-
Englewood, New Jersey, United States, 07631
- Hematology Oncology Physicians of Englewood, PA
-
Neptune, New Jersey, United States, 07753
- Meridian Health Systems
-
New Brunswick, New Jersey, United States, 08901
- Saint Peter's University Hospital
-
Paramus, New Jersey, United States, 07652
- The Valley Hospital
-
Williamstown, New Jersey, United States, 08360
- Southern Oncology Hematology Associates
-
-
New Mexico
-
Farmington, New Mexico, United States, 87401
- San Juan Oncology Associates
-
-
New York
-
Bronx, New York, United States, 10469
- Eastchester Center for Cancer Care
-
East Hills, New York, United States, 11548
- St. Francis Hospital
-
East Setauket, New York, United States, 11733
- North Shore Hematology Oncology Associates, PC
-
East Syracuse, New York, United States, 13057
- Hematology Oncology Associates of Central New York
-
Glens Falls, New York, United States, 12801
- Glen Falls Hospital Cancer Center
-
Manhasset, New York, United States, 11030
- North Shore Long Island Jewish Hospital
-
Mount Kisco, New York, United States, 10549
- Northern Westchester Hospital
-
New York, New York, United States, 10016
- MHO Research Foundation, Inc.
-
Nyack, New York, United States, 10960
- Hematology Oncology Associates of Rockland
-
Syracuse, New York, United States, 13210
- SUNY Upstate Medical Center
-
White Plains, New York, United States, 10601
- White Plains Hospital
-
Williamsville, New York, United States, 14221
- Ccs Oncology
-
-
North Carolina
-
Cary, North Carolina, United States, 27518
- Waverly Hematology Oncology
-
Charlotte, North Carolina, United States, 28204
- Levine Cancer Institute
-
Greenville, North Carolina, United States, 27834
- Leo Jenkins Cancer Center/ECU School of Medicine
-
Morehead City, North Carolina, United States, 28557
- Raab Clinic
-
-
Ohio
-
Cleveland, Ohio, United States, 44195
- Cleveland Clinic
-
Columbus, Ohio, United States, 43219
- Mid Ohio Oncology Hematology, DBA The Mark H. Zangmeister Center
-
Middletown, Ohio, United States, 45005
- Wright State University
-
Toledo, Ohio, United States, 43623
- Toledo Community Hospital Oncology Program - CCOP Toledo
-
Youngstown, Ohio, United States, 44501
- St. Elizabeth Hospital
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73120
- Mercy Research - Mercy Clinic Oncology and Hematology
-
-
Oregon
-
Eugene, Oregon, United States, 97401
- Willamette Valley Cancer Institute and Research Center
-
Medford, Oregon, United States, 97504
- Hematology Oncology Associates, PC
-
Medford, Oregon, United States, 97504
- Hematology Oncology Associates
-
Portland, Oregon, United States, 97213-2982
- Compass Oncology- Hoyt
-
Portland, Oregon, United States, 97225
- Compass Oncology- Barnes
-
Portland, Oregon, United States, 97227
- Compass Oncology- Broadway
-
Springfield, Oregon, United States, 97477
- Willamette Valley Cancer Institute and Research Center
-
Tualatin, Oregon, United States, 97062
- Compass Oncology- Tualatin
-
-
Pennsylvania
-
Lancaster, Pennsylvania, United States, 17605
- Lancaster Cancer Center
-
Monroeville, Pennsylvania, United States, 15232
- University Cancer Institute, LLC
-
Philadelphia, Pennsylvania, United States, 19141
- Einstein Medical Center
-
Scranton, Pennsylvania, United States, 18510
- Hematology & Oncology Associates of Northeastern PA
-
Williamsport, Pennsylvania, United States, 17701
- Susquehanna Cancer Center
-
York, Pennsylvania, United States, 17403
- Cancer Care Associates of York
-
-
South Carolina
-
Charleston, South Carolina, United States, 29406
- Charleston Cancer Center
-
Easley, South Carolina, United States, 29640
- Cancer Centers of the Carolinas- Easley
-
Greenville, South Carolina, United States, 29605
- Cancer Centers of the Carolinas- Butternut
-
Greenville, South Carolina, United States, 29605
- Hematology and Oncology Associates of SC, LLC
-
Greenville, South Carolina, United States, 29615
- Greenville Hospital System Medical Center
-
Greer, South Carolina, United States, 29650
- Greenville Health System
-
Hilton Head Island, South Carolina, United States, 29926
- South Carolina Cancer Specialists
-
Rock Hill, South Carolina, United States, 29732
- Carolina Blood and Cancer Care Associates
-
Seneca, South Carolina, United States, 29672
- Cancer Centers of the Carolinas - Seneca
-
Spartanburg, South Carolina, United States, 29303
- Spartanburg Regional Healthcare System
-
Spartanburg, South Carolina, United States, 29307
- Cancer Centers of the Carolinas- Spartanburg
-
-
South Dakota
-
Watertown, South Dakota, United States, 57201
- Prairie Lakes Hospital
-
-
Tennessee
-
Cookeville, Tennessee, United States, 38501
- Cookeville Regional Medical Center
-
Jackson, Tennessee, United States, 38301
- Jackson Madison County General Hospital
-
Nashville, Tennessee, United States, 37232
- Vanderbilt University Medical Center
-
Nashville, Tennessee, United States, 37208
- Meharry Medical College
-
-
Texas
-
Abilene, Texas, United States, 79601
- Hendrick Cancer Center
-
Abilene, Texas, United States, 79606-5208
- Texas Oncology - Abilene
-
Allen, Texas, United States, 75013
- Texas Oncology- Allen
-
Amarillo, Texas, United States, 79106
- Texas Oncology - Amarillo
-
Arlington, Texas, United States, 76012
- Texas Oncoogy - Arlington North
-
Arlington, Texas, United States, 76014
- Texas Oncology- Arlington South
-
Austin, Texas, United States, 78705
- Texas Oncology - Austin Midtown
-
Austin, Texas, United States, 78731
- Texas Oncology - P.A.- Austin
-
Austin, Texas, United States, 78745
- South Austin Cancer Center
-
Beaumont, Texas, United States, 77701
- Texas Oncology - PA
-
Beaumont, Texas, United States, 77702
- Texas Oncology, P.A - Beaumont
-
Bedford, Texas, United States, 76022
- Texas Oncology-Bedford
-
Carrollton, Texas, United States, 75010
- Texas Oncology - Carrollton
-
Dallas, Texas, United States, 75231
- Texas Oncology - Dallas Presbyterian
-
Dallas, Texas, United States, 75246
- Baylor Charles A. Sammons Cancer Center
-
El Paso, Texas, United States, 79902
- El Paso Cancer Treatment Center- West
-
El Paso, Texas, United States, 79915
- Texas Oncology - P.A. - El Paso
-
El Paso, Texas, United States, 79939
- Texas Oncology - El Paso
-
Flower Mound, Texas, United States, 75028
- Texas Oncology, P.A.- Flower Mound
-
Grapevine, Texas, United States, 76051
- Texas Oncology-Grapevine
-
Harlingen, Texas, United States, 78550
- Texas Oncology Pa
-
Longview, Texas, United States, 75601
- Texas Oncology - P.A.- Longview
-
McAllen, Texas, United States, 78503
- Texas Oncology - P.A.-McAllen
-
McKinney, Texas, United States, 75071
- Texas Oncology- Mckinney
-
Mesquite, Texas, United States, 75150
- Texas Oncology -P.A.- Mesquite
-
Midland, Texas, United States, 79701
- Texas Oncology - P.A.- Midland
-
Odessa, Texas, United States, 79761
- Texas Oncology - P.A.- Odessa
-
Paris, Texas, United States, 75460-5004
- Texas Oncology - P.A.- Paris
-
Plano, Texas, United States, 75075-7787
- Texas Oncology - P.A.- Plano
-
Plano, Texas, United States, 75093
- Texas Oncology- Plano West
-
Rockwall, Texas, United States, 75032
- Texas Oncology - Rockwall
-
San Antonio, Texas, United States, 78212
- Texas Oncology- San Antonio Downtown
-
San Antonio, Texas, United States, 78217
- Texas Oncology- San Antonio Northeast
-
San Antonio, Texas, United States, 78258
- Texas Oncology- San Antonio Stone Oak
-
Sherman, Texas, United States, 75090
- Texas Oncology - P.A.-Sherman
-
Sugar Land, Texas, United States, 77479
- Texas Oncology - P.A.-Sugar Land
-
Tyler, Texas, United States, 75701
- Tyler Hematology Oncology
-
Tyler, Texas, United States, 75702
- Texas Oncology-P.A-Tyler
-
Waco, Texas, United States, 76712
- Texas Oncology, P.A. - Horizon Circle
-
Waco, Texas, United States, 76712
- Texas Oncology, P.A. - Waco
-
Webster, Texas, United States, 77598-4420
- Texas Oncology-P.A.- Webster
-
Weslaco, Texas, United States, 78596
- Texas Oncology-Weslaco
-
-
Virginia
-
Newport News, Virginia, United States, 23601
- Cancer Specialists of Tidewater
-
Winchester, Virginia, United States, 22601
- Shenandoah Oncology, P.C.
-
-
Washington
-
Everett, Washington, United States, 98201
- Providence Everett Medical Center
-
Seattle, Washington, United States, 98104
- Swedish Cancer Institute
-
Tacoma, Washington, United States, 98405
- MultiCare Institute for Research and Innovation
-
Vancouver, Washington, United States, 98684
- Compass Oncology
-
Walla Walla, Washington, United States, 99362
- Providence St. Mary Regional Cancer Center
-
Yakima, Washington, United States, 98902
- Yakima Valley Memorial Hospital/North Star Lodge
-
-
Wisconsin
-
Green Bay, Wisconsin, United States, 54301
- HSHS St. Vincent Hospital Regional Cancer Center
-
Waukesha, Wisconsin, United States, 53188
- ProHealth Care
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
The registry will aim to enroll approximately 1500 patients with CLL/SLL from a total of 200 sites in the US over a 45 month enrollment period.
In order to best capture real-world treatment patterns, site recruitment will aim to include approximately 85% of sites from the community hematology-oncology setting.
Description
Inclusion Criteria:
- Age of at least 18 years
- Clinical diagnosis of CLL/SLL that meets published diagnostic criteria (Hallek 2008)
- Initiating anti-CLL/SLL treatment regimen (excluding clinical trials) within ±45 days of enrollment
- Availability of documentation of previous CLL/SLL treatment and duration of response in the patient's medical records if patient has received prior line(s) of treatment (i.e. NOT treatment naïve)
- Willing and able to provide informed consent
- Willing and able to complete PRO instrument
- Willing and able to provide information on patient survey questionnaire
- Willing and able to provide a blood sample at time of enrollment prior to receiving treatment, as possible
Exclusion Criteria:
- Diagnosis of B-cell malignancies other than CLL/SLL
- Estimated life expectancy <6 months
- Currently receiving treatment in an interventional clinical trial at time of entry into this study * Note- Exceptions: 1) Patients may enroll in interventional clinical trials for indications other than CLL/SLL, 2) The interventional clinical trial treatment is not the treatment used for meeting Inclusion Criteria #2 (or "Index Treatment"), 3) Patients may enroll in an interventional clinical trial indicated for CLL/SLL as later line of treatment after discontinuing the Index Treatment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
|---|
|
Patient with CLL/SLL
Patients with CLL/SLL in a real-world setting initiating treatment with approved oral kinase inhibitors, BCL-2 inhibitors and other approved anti-CLL therapies/regimens.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Summarize baseline characteristics of study population, among CLL patients in a real-world setting
Time Frame: up to 7 years
|
- Summarize baseline characteristics of study participants
|
up to 7 years
|
|
Summarize treatment patterns among CLL patients in a real-world setting
Time Frame: up to 7 years
|
|
up to 7 years
|
|
Summarize clinical outcomes among CLL patients in a real-world setting
Time Frame: up to 7 years
|
- Measures of effectiveness used will include survival status, ECOG Health status, response assessments as evaluated by the investigator such as: complete response, partial response, stable disease, progressive disease
|
up to 7 years
|
|
Summarize health care resource utilization among CLL patients in a real-world setting
Time Frame: up to 7 years
|
- Summarize health care resource utilization among study participants
|
up to 7 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Summarize non serious adverse events (AEs) that led to discontinuation/modification/interruption of therapy and all serious adverse events in CLL patients
Time Frame: up to 7 years
|
- Summarize frequencies and percentages of AEs, that led to discontinuation/modification/interruption of therapy or death in CLL patients
|
up to 7 years
|
|
Summarize patient-reported HRQoL scores
Time Frame: up to 7 years
|
- Summarize HRQoL scores as measured by FACT-G and additional questions from other PRO instruments at baseline and each follow-up
|
up to 7 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Alex Young, Pharmacyclics LLC.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2015
Primary Completion (Actual)
July 21, 2021
Study Completion (Actual)
July 21, 2021
Study Registration Dates
First Submitted
September 8, 2015
First Submitted That Met QC Criteria
October 19, 2015
First Posted (Estimate)
October 21, 2015
Study Record Updates
Last Update Posted (Actual)
July 22, 2022
Last Update Submitted That Met QC Criteria
July 19, 2022
Last Verified
July 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PCYC-1134M-CA
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Lymphocytic Leukemia (CLL)
-
Hackensack Meridian HealthCelgene CorporationTerminatedSmall Lymphocytic Lymphoma | Chronic Lymphocytic Leukemia(CLL)United States
-
Piramal Enterprises LimitedDana-Farber Cancer Institute; Norris Cotton Cancer CenterSuspendedRelapsed/Refractory Chronic Lymphocytic Leukemia (CLL)United States
-
Virginia Commonwealth UniversityGilead SciencesWithdrawnChronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | CLL | Refractory Small Lymphocytic Lymphoma | SLL | Relapsed CLL | Relapsed Chronic Lymphocytic Leukemia | Relapsed Small Lymphocytic Lymphoma
-
Newave Pharmaceutical IncRecruitingCLL | CLL (Chronic Lymphocytic Leukemia) | CLL, Relapsed | CLL, Refractory | SLL | SLL (Small Lymphocytic Lymphoma) | CLL Progression | CLL / SLLUnited States
-
Tampere University HospitalCompleted
-
AstraZenecaActive, not recruitingChronic Lymphocytic Leukaemia (CLL)Germany
-
AbbVieCompletedCancer, Chronic Lymphocytic Leukemia (CLL)South Korea
-
AstraZenecaCLL ConsortiumCompletedB Cell Lymphomas | 11q-deleted Relapsed/Refractory Chronic Lymphocytic Leukaemia (CLL), | Prolymphocytic Leukaemia (PLL)United States
-
Memorial Sloan Kettering Cancer CenterPharmacyclics LLC.WithdrawnChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | CLL | CLL/SLL | SLLUnited States
-
French Innovative Leukemia OrganisationRoche Pharma AGCompletedB-cell Chronic Lymphocytic Leukemia CLLFrance